Tag: Seiji Hirasaki
Moderna to acquire Oriciro Genomics
Moderna, Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and OriCiro Genomics K.K., a pioneer in cell-free DNA synthesis and amplification technologies, recently announced they have entered into a definitive agreement through which Moderna will acquire OriCiro for $85 million.
Featured Article
Beyond insights: CRM’s transformative role in sustainable manufacturing
Manufacturing companies worldwide are increasingly gearing up for a significant transformation with environmental sustainability at the centre. This comes amid stronger environmental regulations, a shift in consumer behaviour, and the industrial sector delves deeper into Industry 4.0.
